Barclays Capital today reaffirms its overweight investment rating on Intermediate Capital Group PLC (LON:ICP) and raised its price target to 1520p (from 1470p).
Thermal processing services provider Bodycote said revenue fell 30% in April as its businesses outside of China had experienced the biggest impact from the Covid-19...
Clinical stage biotherapeutics company PureTech Health has announced plans to advance its product candidate LYT-100 (deupirfenidone) as a potential treatment for serious respiratory complications that...